Abstract Purpose of Review Coronavirus disease 2019 (COVID-19) has been the cause of
significant global morbidity and mortality. Here, we review the literature to date of the short …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV 2) or coronavirus disease
2019 (COVID-19) initially surfaced in December 2019 from Wuhan, China, sweeping the …

Background Myocardial injury and inflammation at cardiac MRI in patients with COVID-19
have been described in recent publications. Concurrently, a chronic COVID-19 syndrome …

Viral myocarditis is inflammation of the myocardium secondary to viral infection. The clinical
presentation of viral myocarditis is very heterogeneous and can range from nonspecific …

COVID-19 has shown significant morbidity with the involvement of multiple systems,
including the cardiovascular system. Cardiovascular manifestations in the acute phase can …

Objective COVID-19 infection is a systemic disease with various cardiovascular symptoms
and complications. Cardiac MRI with late gadolinium enhancement is the modality of choice …

In the era of the coronavirus disease 2019 (COVID-19) pandemic, acute cardiac injury (ACI),
as reflected by elevated cardiac troponin above the 99th percentile, has been observed in …

In recent months, much of the scientific efforts have focused on research on SARSCoV-2
infection and its consequences in humans. Still, many aspects remain unknown. It is known …

Abstract 603,711,760 confirmed cases of COVID-19 have been reported throughout the
world and 6,484,136 individuals have died from complications of COVID-19 as of September …

Aims The cardiac injury and sequelae of Delta Variant of coronavirus disease 2019 (COVID‐
19) remain unknown. This study aimed to evaluate the presence of cardiac involvement in …